Recent data have linked two different rare mutations in the a synuclein gene with early onset familial Parkinson's disease. We and other have found a synuclein immunoreactivity to be present in Lewy bodies and other pathological lesions in the Parkinson disease brain, even in sporadic cases. These data suggest that a synuclein plays a critical role in the disease process. a Synuclein is predominantly expressed in neurons. Its function is unknown. This proposal will study a synuclein using three complementary systems: human brain samples, tranfected primary hippocampal or brain stem neurons, and over-expressing transgenic mice. We have developed novel applications of confocal scanning laser microscopy and fluorescence resonance energy transfer (FRET) to study the subcellular distribution of a synuclein and a synuclein-ubiquitin conjugates in brain. Transfection of primary neurons with Green Fluorescent Protein-alpha synuclein fusion constructs reveals a membrane association at presynaptic specializations in living neurons- application of FRET techniques to these neurons will be used to study a synuclein intramolecular interactions with membranes, and gain insight into a synuclein (and mutant a synuclein) conformation. Moreover, a synuclein GFP changes its location and merges with the membrane upon depolarization. We will study the impact of the mutations and of other stimuli such as MPP+ on this phenomenon using 2 photon confocal microscopy. We will also propose to generate transgenic mice with wild type and both mutant forms of a synuclein using the hamster PrP promoter which has previously been successful in other neurodegenerative disease models. We will build on the results of aims #1 and #2 to anatomically phenotype the mice, as well as relying on the resources of the Center to examine the mice for behavioral or electrophysiological (Dr. Graybiel) or neurochemical (Dr. Penny) abnormalities. Together, we propose an integrated, comprehensive approach to understanding the role of a synuclein in Lewy body diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS038372-02
Application #
6219189
Study Section
Project Start
1999-09-01
Project End
2000-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Caraveo, Gabriela; Soste, Martin; Cappelleti, Valentina et al. (2017) FKBP12 contributes to ?-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. Proc Natl Acad Sci U S A 114:E11313-E11322
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80
Nuytemans, Karen; Inchausti, Vanessa; Beecham, Gary W et al. (2014) Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Mov Disord 29:827-30
Hernandez, Ledia F; Kubota, Yasuo; Hu, Dan et al. (2013) Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci 33:4782-95
Lemaire, Nuné; Hernandez, Ledia F; Hu, Dan et al. (2012) Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by L-DOPA. Proc Natl Acad Sci U S A 109:18126-31
Tardiff, Daniel F; Tucci, Michelle L; Caldwell, Kim A et al. (2012) Different 8-hydroxyquinolines protect models of TDP-43 protein, ?-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287:4107-20
Klucken, Jochen; Poehler, Anne-Maria; Ebrahimi-Fakhari, Darius et al. (2012) Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8:754-66
Lin, Michael T; Cantuti-Castelvetri, Ippolita; Zheng, Kangni et al. (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol 71:850-4
Unni, Vivek K; Ebrahimi-Fakhari, Darius; Vanderburg, Charles R et al. (2011) Studying protein degradation pathways in vivo using a cranial window-based approach. Methods 53:194-200
Ticozzi, Nicola; LeClerc, Ashley Lyn; van Blitterswijk, Marka et al. (2011) Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiol Aging 32:2096-9

Showing the most recent 10 out of 87 publications